INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $26,586 | -99.0% | 762 | -98.5% | 0.00% | -100.0% |
Q3 2022 | $2,781,000 | -10.5% | 49,689 | +28.3% | 0.01% | -40.0% |
Q1 2021 | $3,107,000 | -31.4% | 38,720 | -53.5% | 0.02% | -40.0% |
Q4 2020 | $4,526,000 | +382.5% | 83,193 | +45.1% | 0.02% | +316.7% |
Q2 2019 | $938,000 | +20.3% | 57,321 | +25.6% | 0.01% | +20.0% |
Q1 2019 | $780,000 | +21.9% | 45,646 | -2.7% | 0.01% | 0.0% |
Q4 2018 | $640,000 | – | 46,911 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |